missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD40 Ligand/TNFSF5 Antibody (40804) [Janelia Fluor™ 549], Novus Biologicals™
Mouse Monoclonal Antibody
Marke: Novus Biologicals FAB617I
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
CD40 Ligand/TNFSF5 Monoclonal antibody specifically detects CD40 Ligand/TNFSF5 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Blockade of Receptor-ligand Interaction, CyTOF
Spezifikation
| CD40 Ligand/TNFSF5 | |
| Monoclonal | |
| Janelia Fluor 549 | |
| 50mM Sodium Borate | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| Primary | |
| Human | |
| Purified |
| Western Blot, Flow Cytometry, Immunohistochemistry, Blockade of Receptor-ligand Interaction, CyTOF | |
| 40804 | |
| Western Blot, Flow Cytometry, Immunohistochemistry, Blockade of Receptor-ligand Interaction, CyTOF-ready | |
| CD154, CD154 antigen, CD40 antigen ligand, CD40 ligand, CD40-L, CD40LIGM, gp39, hCD40L, HIGM1, T-B cell-activating molecule, T-BAM, T-cell antigen Gp39, TNF-related activation protein, TNFSF5IMD3, TRAPtumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome), tumor necrosis factor (ligand) superfamily member 5, Tumor necrosis factor ligand superfamily member 5 | |
| E. coli-derived recombinant human CD40 Ligand/TNFSF5, Leu50-Leu261, Accession # P29965 | |
| 0.1 mL | |
| Adaptive Immunity, Apoptosis, Asthma, Biologically Active Proteins, Breast Cancer, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, Hypoxia, Immunology, Innate Immunity, Mast Cell Markers, Mesenchymal Stem Cell Markers, Myeloid Cell Markers, Neuronal Cell Markers, Neuroscience, Stem Cell Markers, Tumor Suppressors | |
| 959 | |
| Store at 4°C in the dark. | |
| IgG2b |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur